Preclinical and clinical data, though predominantly derived from case reports and small cohort studies to date, consistently indicate that GLP-1 RAs - including liraglutide, semaglutide, and the dual GIP/GLP-1 RA tirzepatide - can induce clinically meaningful weight loss, suppress the characteristic severe hyperphagia, and improve key cardiometabolic parameters in both heterozygous and homozygous MC4R variant carriers
Vital Flow offers quick shots for energy, focus, immune support, metabolism, recovery, wellness, and relief, with guidance from licensed medical professionals so you can choose the option that fits your goals
Discuss any new beverage or supplement routine with your provider, especially if you experience nausea, heart palpitations, or other side effects while on GLP-1 therapy
One of tirzepatides most important therapeutic mechanisms is its ability to regulate appetite